Serum tumor marker in rodent prostate cancer models
US7732564B2 · kind B2 · utility
0Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2006 |
| Grant date | Jun 8, 2010 |
| Priority date | — |
| Expiry date | Mar 6, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/82
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a rodent serum marker for prostate cancer comprising b-microseminoprotein (PSP94) and diagnostic methods thereof. The present invention also relates to a recombinant sequence to raise a ligand of a specific binding affinity to a rodent serum marker for prostate cancer, which comprises the following amino acid sequence:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.